Skip to main content
Earnings Labs
Supernus Pharmaceuticals, Inc. logo

Supernus Pharmaceuticals, Inc. (SUPN) Earnings

NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic

$44.56

-2.17%

Mkt Cap $2.64B

EPS — Estimate vs Actual

Mkt Cap

$2.64B

P/E

Fwd P/E

25.99

P/S

3.40

Rev TTM

EPS TTM

-$0.51